Head-to-head · free
Sony vs SURG
SONY vs SURG — return on capital, cash generation, margins and balance sheet side by side.
SONY
7 / 8
measures where SONY leads
SURG
1 / 8
measures where SURG leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | SONY · FY2025 | SURG · FY2025 |
|---|---|---|
| Revenue | $12.48T | $57.0M |
| Net income | (326.9B) | (36.1M) |
| Revenue growth (yearly, multi-year) | 5.9% | 2.8% |
| Free cash flow | $1.49T | (21.3M) |
| Free cash flow margin | 11.9% | -37.4% |
| Net cash / (debt) | $539.2B | — |
| ROIC | 9.3% | — |
| Return on equity | -4.0% | — |
| Gross margin | 30.8% | -18.6% |
| Operating margin | 12.4% | -53.8% |
| Net debt / EBITDA | -0.44x | -0.35x |
Figures are as reported by each company; latest fiscal year shown.
Where Sony's cash went (FY2025)
- Capital spending
- $457.7B
- Buybacks
- $522.1B
- Dividends
- $135.0B
- Acquisitions
- $136.0B
- Net debt issued / (repaid)
- (103.6B)
Where SURG's cash went (FY2025)
- Capital spending
- $18590
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free